baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Morgan Stanley Discount Zert LLY .../ DE000ME908E7 /

2024-05-31 8:21:18 PM	Chg.-0.21	Bid10:00:35 PM	Ask10:00:35 PM	Underlying	Strike price	Expiration date	Option type
67.19EUR	-0.31%	- Bid Size: -	- Ask Size: -	ELI LILLY	- -	2025-06-27	Call

GlobeNewswire 2:00 AM HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine

GlobeNewswire 05-30 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024

GlobeNewswire 05-30 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More

GlobeNewswire 05-24 Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District

TeleTrader 05-24 Eli Lilly to reveal $5.3B production boost

GlobeNewswire 05-23 Gov. Holcomb elevates Indiana to the world’s stage at Global Economic Summit

GlobeNewswire 05-23 Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...

TeleTrader 05-21 Eli Lilly's diabetes drug receives authorization in China

GlobeNewswire 05-16 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...

GlobeNewswire 05-16 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly

GlobeNewswire 05-16 HEPHAISTOS secures €10.3 M to reach the clinical stage

GlobeNewswire 05-15 Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member

GlobeNewswire 05-13 Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...

GlobeNewswire 05-09 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...

GlobeNewswire 05-09 Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radioph...

GlobeNewswire 05-09 ProQR Announces First Quarter 2024 Operating and Financial Results

GlobeNewswire 05-08 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update

GlobeNewswire 05-08 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...

GlobeNewswire 05-08 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO

GlobeNewswire 05-08 ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting...

GlobeNewswire 05-08 Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results

GlobeNewswire 05-03 BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and U...

GlobeNewswire 05-01 H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors

GlobeNewswire 04-30 ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors

Morgan Stanley Discount Zert LLY .../ DE000ME908E7 /

If you wish to receive reply to your feedback, please provide your email address.